UNSPSC 51421902: Locicortolone

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G87210HO7A. European Medicines Agency schedules Locicortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08546MIG. LThe term LOCICORTOLONE is an International Non-Proprietary Name or INN. As of Q4 2014, LOCICORTOLONE remains the US FDA Preferred Term for this commodity. SMILES: CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)OC(C5CCCCC5)C6CCCCC6)C)Cl)Cl)C.

UNSPSC 51421902 Locicortolone is a Commodity code that maps inconsistently to recent state and local procurement activity. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure naloxone and drug deactivation systems—a harm-reduction and emergency-response product line unrelated to the code's nominal pharmaceutical classification. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer pharmacy prescription programs, also outside the locicortolone scope. The mismatch suggests the code sees minimal relevant recent activity under its actual product definition, or that state and local procurement offices are tagging harm-reduction and pharmacy-benefit opportunities to this code despite the semantic misalignment.

Geographically, recent opportunities cluster in Texas and Florida, with the Seminole County solicitation requiring quarterly deliveries to Sanford, Florida under a two-year base term with one-year renewal option, and the Texas HHS RFI serving as exploratory market research prior to formal RFP issuance. Issuing bodies include a county health system and a state agency, both pursuing health-sector procurement. Because neither opportunity directly addresses the locicortolone pharmaceutical itself, pursuit under this code would require vendor alignment with harm-reduction supply chains or pharmacy benefit management infrastructure rather than the steroid pharmaceutical the code nominates.